ArticleBreast cancer research : BCR2020

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.

Neil Portman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.